Diabetes Drugs and Cancer
Our diabetes drug lawsuit attorneys are helping individuals nationwide who have been diagnosed with Pancreatic Cancer or Thyroid Cancer after taking diabetes medications like Januvia or Byetta. If you or a loved one developed cancer after taking diabetes drugs, you may be eligible to file Januvia lawsuit or Byetta lawsuit settlement claims in 2015. Call 1-888-578-4754 today for a free, no-obligation case review.
On March 14, 2013, the FDA announced a new investigation of the possible link between certain diabetes drugs and pancreatic cancer.1 The Agency stated that it was evaluating unpublished research which may show that diabetics on certain medications are at an increased risk of pancreatitis and pre-cancerous pancreatic growths.
Before this FDA investigation was announced, a number of scientific studies indicated an elevated risk of pancreatic cancer in patients prescribed medications from a class of diabetes drugs called incretin mimetics.
Researchers Investigate Byetta and Januvia Pancreatic Cancer
Incretin mimetics treat type 2 diabetes by causing the body to produce more insulin. Some, like Byetta and Victoza, increase levels of GLP-1, a hormone that stimulates insulin secretion. Others, like Januvia, Onglyza, Tradjenta, and Nesina, prevent a protein called DPP-4 from breaking down GLP-1. Both types are effective diabetes medications, but, unfortunately, may be linked to potentially deadly side effects like acute pancreatitis and pancreatic cancer.
In 2011, a study by researchers at UCLA found that patients prescribed two incretin mimetics, Byetta and Januvia, were at a six-times-greater risk of pancreatitis than diabetics on other treatments.2 The researchers noted that the rates of pancreatic cancer in patients taking Byetta and Januvia were 2.9 and 2.7 times greater, respectively, than the cancer rates of diabetes patients on other kinds of treatments.
Byetta May Also Be Linked to Thyroid Cancer
Among patients taking Byetta (exenatide) the risk of thyroid cancer also appeared elevated; exenatide users reported thyroid cancer at 4.7 times the rate of other diabetics. Dr. Peter Butler, the chairman of endocrinology at UCLA, warned that the results of the study were preliminary and did not definitively show that incretin mimetics cause cancer. However, he has publicly stated that he does not prescribe incretin mimetics to his own patients.
Diabetes Drug Lawsuit Attorney
Our law firm represents those who have developed pancreatic or thyroid cancer after taking certain diabetes medications, as well as the families of individuals who died of pancreatic cancer after taking one of these drugs. We represent all clients on a contingency basis, which means there are never any legal fees unless we win compensation in your case.
Contact us for a free legal consultation and a diabetes drug lawsuit attorney will be available to answer your questions about diabetes drugs and cancer.